Insider / Elanco Animal Health Inc
Simmons Jeffrey N
PRESIDENT, CEO AND DIRECTOR at Elanco Animal Health Inc
- Company
- Elanco Animal Health Inc
- Ticker
- ELAN
- First filing on record
- October 7, 2025
- Latest trade on record
- October 16, 2026
- SEC filings
- EDGAR ↗
Simmons Jeffrey N, PRESIDENT, CEO AND DIRECTOR at Elanco Animal Health Inc, has disclosed 36 transactions in ELAN since October 7, 2025: 2 purchases (2 open-market buys) and 2 sales, worth about $7.8M at the reported prices. The latest was filed October 20, 2026, 4 days after the trade; 1 filing was late against the 2-business-day Form 4 deadline.
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
In the last 12 months Simmons Jeffrey N made 2 purchases worth $578K and 2 sales worth $7.0M, plus 30 other transactions. Dot size is the dollar amount.
Portfolio mix
Which stocks does this person trade most? Tile size is dollars traded, all time on record.
Simmons Jeffrey N has traded 1 stock on record; the largest by dollars is ELAN.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
1 of 31 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| A | Grant or award | 32 | 774,545 | $181K |
| F | Shares withheld for tax | 2 | 267,880 | $7.0M |
| P | Open-market purchase | 2 | 26,971 | $578K |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 28 | 1 · $100K | 2 · $7.0M |
| 2025 | 8 | 1 · $478K | 0 |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| ELAN | Other A | October 16, 2026 | October 20, 2026 | 4d | 120 | $24 | $2,827 | derivative | Form 4 ↗ | |
| ELAN | Other A | October 2, 2026 | October 6, 2026 | 4d | 128 | $22 | $2,827 | derivative | Form 4 ↗ | |
| ELAN | Other A | September 18, 2026 | September 22, 2026 | 4d | 126 | $22 | $2,827 | derivative | Form 4 ↗ | |
| ELAN | Other A | September 4, 2026 | September 9, 2026 | 5d | 115 | $25 | $2,827 | latederivative | Form 4 ↗ | |
| ELAN | Other A | August 21, 2026 | August 25, 2026 | 4d | 118 | $24 | $2,827 | derivative | Form 4 ↗ | |
| ELAN | Other A | August 7, 2026 | August 10, 2026 | 3d | 128 | $22 | $2,827 | derivative | Form 4 ↗ | |
| ELAN | Other A | July 24, 2026 | July 28, 2026 | 4d | 113 | $25 | $2,827 | derivative | Form 4 ↗ | |
| ELAN | Other A | July 10, 2026 | July 14, 2026 | 4d | 114 | $25 | $2,827 | derivative | Form 4 ↗ | |
| ELAN | Other A | June 26, 2026 | June 30, 2026 | 4d | 115 | $25 | $2,827 | derivative | Form 4 ↗ | |
| ELAN | Other A | June 12, 2026 | June 16, 2026 | 4d | 117 | $24 | $2,827 | derivative | Form 4 ↗ | |
| ELAN | Other A | May 29, 2026 | June 2, 2026 | 4d | 119 | $24 | $2,827 | derivative | Form 4 ↗ | |
| ELAN | Other A | May 15, 2026 | May 19, 2026 | 4d | 142 | $20 | $2,827 | derivative | Form 4 ↗ | |
| ELAN | Buy P | May 15, 2026 | May 19, 2026 | 4d | 4,971 | $20 | $100K | indirect | Form 4 ↗ | |
| ELAN | Other A | May 1, 2026 | May 5, 2026 | 4d | 126 | $23 | $2,827 | derivative | Form 4 ↗ | |
| ELAN | Other A | April 17, 2026 | April 21, 2026 | 4d | 119 | $24 | $2,827 | derivative | Form 4 ↗ | |
| ELAN | Other A | April 3, 2026 | April 7, 2026 | 4d | 124 | $23 | $2,827 | derivative | Form 4 ↗ | |
| ELAN | Other A | March 20, 2026 | March 24, 2026 | 4d | 118 | $24 | $2,827 | derivative | Form 4 ↗ | |
| ELAN | Other A | March 6, 2026 | March 10, 2026 | 4d | 4,498 | $23 | $105K | derivative | Form 4 ↗ | |
| ELAN | Sell F | March 3, 2026 | March 5, 2026 | 2d | 37,898 | $25 | $943K | Form 4 ↗ | ||
| ELAN | Other A | March 1, 2026 | March 3, 2026 | 2d | 6,593 | — | — | derivative | Form 4 ↗ | |
| ELAN | Other A | March 1, 2026 | March 3, 2026 | 2d | 243,809 | — | — | derivative | Form 4 ↗ | |
| ELAN | Other A | March 1, 2026 | March 3, 2026 | 2d | 119,319 | — | — | Form 4 ↗ | ||
| ELAN | Sell F | March 1, 2026 | March 3, 2026 | 2d | 229,982 | $26 | $6.1M | Form 4 ↗ | ||
| ELAN | Other A | March 1, 2026 | March 3, 2026 | 2d | 397,041 | — | — | Form 4 ↗ | ||
| ELAN | Other A | February 20, 2026 | February 24, 2026 | 4d | 111 | $25 | $2,769 | derivative | Form 4 ↗ | |
| ELAN | Other A | February 6, 2026 | February 10, 2026 | 4d | 110 | $25 | $2,769 | derivative | Form 4 ↗ | |
| ELAN | Other A | January 23, 2026 | January 27, 2026 | 4d | 113 | $24 | $2,769 | derivative | Form 4 ↗ | |
| ELAN | Other A | January 9, 2026 | January 13, 2026 | 4d | 118 | $23 | $2,769 | derivative | Form 4 ↗ | |
| ELAN | Other A | December 26, 2025 | December 30, 2025 | 4d | 123 | $23 | $2,769 | derivative | Form 4 ↗ | |
| ELAN | Other A | December 12, 2025 | December 16, 2025 | 4d | 130 | $21 | $2,769 | derivative | Form 4 ↗ | |
| ELAN | Buy P | December 11, 2025 | December 15, 2025 | 4d | 22,000 | $22 | $478K | indirect | Form 4 ↗ | |
| ELAN | Other A | November 28, 2025 | December 2, 2025 | 4d | 119 | $23 | $2,769 | derivative | Form 4 ↗ | |
| ELAN | Other A | November 14, 2025 | November 18, 2025 | 4d | 131 | $21 | $2,769 | derivative | Form 4 ↗ | |
| ELAN | Other A | October 31, 2025 | November 4, 2025 | 4d | 125 | $22 | $2,769 | derivative | Form 4 ↗ | |
| ELAN | Other A | October 17, 2025 | October 21, 2025 | 4d | 129 | $21 | $2,769 | derivative | Form 4 ↗ | |
| ELAN | Other A | October 3, 2025 | October 7, 2025 | 4d | 134 | $21 | $2,769 | derivative | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| October 20, 2026 | Form 4 | 0001479079-26-000047 | 1 | published | EDGAR ↗ |
| October 6, 2026 | Form 4 | 0001479079-26-000045 | 1 | published | EDGAR ↗ |
| September 22, 2026 | Form 4 | 0001479079-26-000043 | 1 | published | EDGAR ↗ |
| September 9, 2026 | Form 4 | 0001479079-26-000041 | 1 | published | EDGAR ↗ |
| August 25, 2026 | Form 4 | 0001479079-26-000039 | 1 | published | EDGAR ↗ |
| August 10, 2026 | Form 4 | 0001479079-26-000037 | 1 | published | EDGAR ↗ |
| July 28, 2026 | Form 4 | 0001479079-26-000035 | 1 | published | EDGAR ↗ |
| July 14, 2026 | Form 4 | 0001479079-26-000033 | 1 | published | EDGAR ↗ |
| June 30, 2026 | Form 4 | 0001479079-26-000031 | 1 | published | EDGAR ↗ |
| June 16, 2026 | Form 4 | 0001479079-26-000029 | 1 | published | EDGAR ↗ |
| June 2, 2026 | Form 4 | 0001479079-26-000027 | 1 | published | EDGAR ↗ |
| May 19, 2026 | Form 4 | 0001479079-26-000025 | 2 | published | EDGAR ↗ |
| May 5, 2026 | Form 4 | 0001479079-26-000023 | 1 | published | EDGAR ↗ |
| April 21, 2026 | Form 4 | 0001479079-26-000021 | 1 | published | EDGAR ↗ |
| April 7, 2026 | Form 4 | 0001479079-26-000019 | 1 | published | EDGAR ↗ |
| March 24, 2026 | Form 4 | 0001479079-26-000017 | 1 | published | EDGAR ↗ |
| March 10, 2026 | Form 4 | 0001479079-26-000015 | 1 | published | EDGAR ↗ |
| March 5, 2026 | Form 4 | 0001479079-26-000013 | 1 | published | EDGAR ↗ |
| March 3, 2026 | Form 4 | 0001479079-26-000011 | 5 | published | EDGAR ↗ |
| February 24, 2026 | Form 4 | 0001479079-26-000009 | 1 | published | EDGAR ↗ |
| February 10, 2026 | Form 4 | 0001479079-26-000007 | 1 | published | EDGAR ↗ |
| January 27, 2026 | Form 4 | 0001479079-26-000005 | 1 | published | EDGAR ↗ |
| January 13, 2026 | Form 4 | 0001479079-26-000003 | 1 | published | EDGAR ↗ |
| December 30, 2025 | Form 4 | 0001479079-25-000021 | 1 | published | EDGAR ↗ |
| December 16, 2025 | Form 4 | 0001479079-25-000019 | 1 | published | EDGAR ↗ |
| December 15, 2025 | Form 4 | 0001479079-25-000017 | 1 | published | EDGAR ↗ |
| December 2, 2025 | Form 4 | 0001479079-25-000015 | 1 | published | EDGAR ↗ |
| November 18, 2025 | Form 4 | 0001479079-25-000013 | 1 | published | EDGAR ↗ |
| November 4, 2025 | Form 4 | 0001479079-25-000011 | 1 | published | EDGAR ↗ |
| October 21, 2025 | Form 4 | 0001479079-25-000008 | 1 | published | EDGAR ↗ |
| October 7, 2025 | Form 4 | 0001479079-25-000006 | 1 | published | EDGAR ↗ |
Other insiders at Elanco Animal Health Inc
- Modi Rajeev A. SEE REMARKS 36 rows
- Kurzius Lawrence Erik Director 29 rows
- VanHimbergen Robert M EVP and CFO 28 rows
- de Brabander Ellen Director 16 rows
- Anand Kapila K Director 8 rows
- GARCIA ART A Director 8 rows
- Correia de Simas Jose Manuel SEE REMARKS 7 rows
- Bettington Timothy J SEE REMARKS 6 rows
- Kinard David S SEE REMARKS 6 rows
- O'Neill Shiv GC AND CORP SEC 6 rows
Everyone on file, with contracts and lobbying under the company's name: Elanco Animal Health Inc.
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Options and derivatives on Form 4 Table I = shares. Table II = options and other derivatives.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 31 | 36 | October 7, 2025 | October 20, 2026 | Form 4 list on EDGAR |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.